Effects of 5G Radiation on Skin Health
Official title: Double-blind Randomized Controlled Study of the Effects of 5G Radiation on Skin
Run by Centre Hospitalier Universitaire Vaudois · NCT05933954 · Data updated 2026-11-12
This study is testing how exposure to 5G radiation affects skin health in both healthy people and those with skin conditions to see if there are any differences in how men and women respond.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 42 (estimated) |
| Sponsor | Centre Hospitalier Universitaire Vaudois Academic / other |
| Locations | 1 site (Lausanne, Canton of Vaud) |
| Status | Recruiting |
| Started | January 9, 2024 |
| Main results expected | July 31, 2026 |
| Study ends | September 1, 2026 |
| Registry record updated | March 27, 2026 |
| Trial ID | NCT05933954 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include healthy adults and those with dermatoporosis, atopic dermatitis, or other specified skin conditions aged 18 to 80.
✕Probably not a fit
Patients with recent sunburn, pregnant or lactating women, and those with significant concomitant diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of 5G electromagnetic radiation, specifically at the 27.5 GHz frequency, on skin health. Participants, including healthy volunteers and those with specific skin conditions, will be exposed to controlled 5G parameters. The skin's response will be analyzed using advanced single-cell RNA analysis to assess any changes in cell behavior. The study also aims to explore potential differences in responses between men and women.
Why it matters
Potential benefit: If successful, this study could provide insights into the safety of 5G technology and its effects on skin health.
How similar studies have gone: While studies on electromagnetic radiation effects exist, this specific focus on 5G FR2 waves and skin response is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants will be recruited in accordance with European and Swiss standards for the following groups: Healtyh volunteers or Dermatoporosis defined as a chronic skin fragility syndrome orGorlin Goltz Syndrome defined as OMIM 10940014, or Familial Cylindromatosis or SB Syndrome defined as OMIM 132700/60504114, or XPV defined as OMIM 27875014 or Atopic dermatitis defined as a chronic inflammatory skin disease characterised by eczematous skin lesions and intense pruritus * Able to give informed consent as documented by signature, * Adults, from 18 to 80 yo, according to groups Exclusion Criteria: * Recent intense exposure to sun (defined as causing a sunburn, within the last 7 days) * Pregnant (excluded with a pregnancy test) or lactating women, * Patients taking anti-coagulants * Clinically significant concomitant diseases (cutaneous exam by the specialist), * Active enrolment in another clinical trial, * Participants incapable of judgment or participants under tutelage.
Where it's running
-
Chuv
Lausanne, Canton of Vaud, Switzerland Recruiting
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.